Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
60 seconds · no obligationView Profile
Cancer of the uterus develops in the tissues of the womb, most frequently arising within the inner lining known as the endometrium. It often affects women past menopause, with abnormal vaginal bleeding, discharge, or pelvic discomfort prompting medical evaluation. Determining the most appropriate clinical interventions depends on an in-depth specialist assessment and comprehensive diagnostic staging. Compare hospitals in Turkey that treat Cancer of the Uterus and get a free review of your medical records.

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
OncologyVerified
English · Turkish
60 seconds · no obligationView Profile
Cancer of the uterus develops in the tissues of the womb, most frequently arising within the inner lining known as the endometrium. It often affects women past menopause, with abnormal vaginal bleeding, discharge, or pelvic discomfort prompting medical evaluation. Determining the most appropriate clinical interventions depends on an in-depth specialist assessment and comprehensive diagnostic staging.
Specialty: Oncology
The cost of treating Cancer of the Uterus depends on the diagnosis and the treatment chosen. Doctors first review your medical records — free of charge — and you then receive an itemised quote.
Cancer of the Uterus is treated by Oncology specialists. 2 clinics in Turkey on our platform offer this treatment.
Cancer of the uterus develops in the womb, most frequently starting in the endometrium (the glandular lining). These are known as endometrial carcinomas. Rarer types, termed uterine sarcomas, arise in the muscular uterine wall. The condition primarily affects women after the menopause, though younger women with hormonal imbalances, polycystic ovary syndrome, or Lynch syndrome can also be affected.
Because the endometrial lining bleeds easily when abnormal tissue develops, early symptoms often prompt clinical review. Key signs include:
Early evaluation by hospital gynaecology and oncology specialists allows timely assessment before cancer spreads.
Accurate staging identifies the tumour type, cellular grade, and depth of invasion into the uterine muscle or lymph nodes.
Hospitals in Turkey typically perform the following diagnostic assessments:
To prevent duplicate procedures, travelling patients should compile:
Interventions depend on tumour grade, histological subtype, FIGO stage, and overall fitness. Decisions are made by a multidisciplinary team after reviewing all diagnostic data.
| Option | Typically used when | Things to know |
|---|---|---|
| Surgical Resection | First-line standard for tumours confined to the womb. | Involves total laparoscopic or robotic hysterectomy, removal of ovaries and fallopian tubes, and sentinel lymph node mapping by general surgery or gynaecologic surgical teams. |
| Radiotherapy | Adjuvant therapy for intermediate or high-risk disease, or when surgery is unsafe. | Combines external pelvic beam radiation with vaginal brachytherapy. May cause temporary bowel or bladder irritation. |
| Chemotherapy | Advanced, recurrent, or aggressive variants like serous carcinoma. | Systemic intravenous medications (carboplatin and paclitaxel) target circulating cells. Requires ongoing blood monitoring. |
| Hormone Therapy | Selected low-grade early tumours for fertility preservation, or advanced care. | High-dose progestins slow cancer growth. Requires regular hysteroscopic biopsies to track response. |
Your treating specialist will explain realistic expectations regarding disease control and recovery based on your pathology results.
Organising cancer treatment abroad requires practical scheduling and structured recovery:
Do not travel internationally if you experience red-flag symptoms requiring emergency hospital care:
All treatment decisions must be confirmed directly with your treating doctors following in-person examination and diagnostic review.
Endometrial cancer develops in the endometrium, the glandular inner lining of the uterus. It accounts for more than ninety percent of uterine cancer cases and is commonly diagnosed at an early stage due to abnormal postmenopausal bleeding. In contrast, uterine sarcoma is a rarer, more aggressive malignancy that originates in the muscular wall (myometrium) or supporting connective tissue of the womb, often requiring distinct surgical and oncological management strategies.
Yes, standard surgical management involves a total hysterectomy alongside bilateral salpingo-oophorectomy, which removes both ovaries and fallopian tubes. If you have not yet reached menopause, the removal of the ovaries triggers immediate surgical menopause, causing an abrupt drop in oestrogen. This can lead to hot flushes, night sweats, mood shifts, and vaginal dryness. Your medical team will discuss non-hormonal or symptom-management strategies, as systemic oestrogen replacement is usually contraindicated.
Fertility-sparing treatment is occasionally possible for carefully selected young women who have stage 1A, low-grade (grade 1) endometrioid adenocarcinoma without muscle invasion. This approach uses high-dose progestin therapy alongside strict surveillance with hysteroscopic biopsies every three to six months. However, once childbearing is complete, standard hysterectomy and bilateral salpingo-oophorectomy remain strongly advised to prevent recurrence. Suitability must be determined through comprehensive multidisciplinary assessment and specialized pathology review.
Most patients who undergo uncomplicated minimally invasive (laparoscopic or robotic) hysterectomy can safely travel home by air roughly ten to fourteen days after surgery, once post-operative checks and healing are confirmed. If extensive open abdominal surgery or lymphadenectomy was performed, you may need two to three weeks before travelling. Air travel increases venous thromboembolism risks, so your treating surgeon must provide formal fit-to-fly clearance, compression garments, and potentially temporary blood-thinning medication.
Following treatment for uterine cancer, patients typically undergo clinical surveillance every three to six months for the first two to three years, transitioning to every six to twelve months thereafter. Follow-up appointments involve a physical and pelvic examination, review of symptoms, and targeted imaging if recurrent disease is suspected. Routine cervical or vaginal vault smears are not generally needed, but prompt evaluation is essential if any new vaginal bleeding or pelvic pain arises.
Your request is in!
Your coordinator will contact you — usually within 2 hours, 24/7.
Want a faster, more accurate assessment?
Add photos & medical detailsLeave your number — a coordinator calls you in your language, usually within 15 minutes during office hours.
Thank you!
A coordinator will contact you at the time you chose.